Financing was co-led by Forbion and General Atlantic, with participants such as RA Capital Management, OrbiMed, and Lilly Asia Ventures.

Stada has lined up a new independent chairman and board of directors in a key step for the private equity-backed German drug manufacturer ahead of a listing this year that could be one of Europe's ...